<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0540">
 <label>108</label>
 <element-citation publication-type="journal" id="rf0530">
  <person-group person-group-type="author">
   <name>
    <surname>Sanchez</surname>
    <given-names>G.A.M.</given-names>
   </name>
   <name>
    <surname>Reinhardt</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Ramsey</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Wittkowski</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Hashkes</surname>
    <given-names>P.J.</given-names>
   </name>
   <name>
    <surname>Berkun</surname>
    <given-names>Y.</given-names>
   </name>
  </person-group>
  <article-title>JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies</article-title>
  <source>J Clin Invest</source>
  <volume>128</volume>
  <year>2018</year>
  <fpage>3041</fpage>
  <lpage>3052</lpage>
  <pub-id pub-id-type="doi">10.1172/jci98814</pub-id>
  <pub-id pub-id-type="pmid">29649002</pub-id>
 </element-citation>
</ref>
